title: [Prognostic factors in lymphomas].
abstract: Prognostic factors able to predict lymphoma patient's outcome are necessary to inform the patient and to choose the appropriate treatment. Beside the essential documentation of the pathological lymphoma subtype, several factors (such as age, performance status, Ann Arbor disease stage, LDH level...) easy to assess are used and help to establish prognostic indexes for each lymphoma entity. Numerous biomarkers obtained on fresh or frozen tissue using molecular techniques are currently described and may help to optimize the clinical care of lymphoma patients tomorrow.
authors.affiliation: Hospices civils de Lyon, Université Claude-Bernard, Service d'hématologie Centre hospitalier Lyon-Sud, 69496 Pierre-Bénite Cedex.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Bachy
authors.forename: Gilles
authors.initials: G
authors.lastname: Salles
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000401:mortality*; D011379:Prognosis; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D000069283:Rituximab